Concordia International Corp. (TSE:CXR – Get Free Report) (NASDAQ:CXRX) was down 1.5% during mid-day trading on Monday . The company traded as low as C$25.01 and last traded at C$25.04. Approximately 73,541 shares were traded during trading, an increase of 1,714% from the average daily volume of 4,054 shares. The stock had previously closed at C$25.43.
Concordia International Price Performance
The stock has a 50-day moving average of C$25.04. The stock has a market cap of C$1.22 billion and a PE ratio of 0.07. The company has a debt-to-equity ratio of 457.02, a quick ratio of 1.66 and a current ratio of 2.10.
About Concordia International
Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies.
Read More
- Five stocks we like better than Concordia International
- Do ETFs Pay Dividends? What You Need to Know
- Intuitive Surgical Stock Outperforms Market: Highs on the Horizon
- Stock Market Upgrades: What Are They?
- Has This Leading Tech Stock Halted the AI Surge?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Revolutionary Battery Stock Gains Momentum with 3D Silicon-Anodes
Receive News & Ratings for Concordia International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia International and related companies with MarketBeat.com's FREE daily email newsletter.
